Evaluation of a recombinant plasma kallikrein inhibitor (ecallantide) in cardiac surgery (In Preparation)
Publication
, Journal Article
Levy, JH; Grocott, HP; Tanaka, KA; Szlam, F; Sternlicht, AL; Vega, JD
2016
Duke Scholars
Publication Date
2016
Citation
APA
Chicago
ICMJE
MLA
NLM
Levy, J. H., Grocott, H. P., Tanaka, K. A., Szlam, F., Sternlicht, A. L., & Vega, J. D. (2016). Evaluation of a recombinant plasma kallikrein inhibitor (ecallantide) in cardiac surgery (In Preparation).
Levy, J. H., H. P. Grocott, K. A. Tanaka, F. Szlam, A. L. Sternlicht, and J. D. Vega. “Evaluation of a recombinant plasma kallikrein inhibitor (ecallantide) in cardiac surgery (In Preparation),” 2016.
Levy JH, Grocott HP, Tanaka KA, Szlam F, Sternlicht AL, Vega JD. Evaluation of a recombinant plasma kallikrein inhibitor (ecallantide) in cardiac surgery (In Preparation). 2016;
Levy, J. H., et al. Evaluation of a recombinant plasma kallikrein inhibitor (ecallantide) in cardiac surgery (In Preparation). 2016.
Levy JH, Grocott HP, Tanaka KA, Szlam F, Sternlicht AL, Vega JD. Evaluation of a recombinant plasma kallikrein inhibitor (ecallantide) in cardiac surgery (In Preparation). 2016;
Publication Date
2016